|Videos|March 30, 2017

What Is the Ideal Antimicrobial Stewardship Team?

Emily Heil, PharmD, BCPS-AQ ID, assistant professor at the University of Maryland School of Pharmacy, describes what the ideal antibiotic stewardship team would look like.

Emily Heil, PharmD, BCPS-AQ ID, assistant professor at the University of Maryland School of Pharmacy, and Contagion® Editorial Advisory Board Member, describes what the ideal antibiotic stewardship team would look like.

Interview Transcript (slightly modified for readability)

“The ideal stewardship team would certainly need to be interdisciplinary, so including pharmacist leaders, physician leaders, focusing on folks from your microbiology lab—they can definitely not be forgotten—your lab is a key partner in an effective stewardship team, [and being] partners with infection prevention. I would also argue that your executive administration should be a part of your stewardship team because you really need that leadership support and buy-in to have an effective program. So, having them be actively engaged in your team I think is important as well.”


Related to this article

Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
Treatment of Latent Tuberculosis in a Trice
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.